United Kingdom: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

The New UK Clinical Trials Regulations: Where Does The New Law Leave Injured Trial Participants?

On 28 April 2026, the Medicines for Human Use (Clinical Trials) Amendment regulations 2025 came into force, marking the most significant change to the legal regulation of clinical trials in the UK...

United Kingdom Litigation

AG

Anthony Gold Solicitors LLP

Launching The Latest Edition Of Our Life Sciences And Healthcare Insights

This report examines critical commercial, legal and regulatory challenges facing life sciences and healthcare companies globally, from shareholder activism and AI-powered drug...

United Kingdom Healthcare

AO

A&O Shearman

Navigating IVD Regulation In Clinical Trials: A Comparative EU And UK Guide

Assays used in clinical trials vary widely in complexity and regulatory status.. They may be fully developed and marketed as in vitro diagnostic medical devices (IVDs), including companion diagnostics (CDx)...

European Union Healthcare

AP

Arnold & Porter

The Never-ending Licence That Ended: Court Of Appeal Clarifies Licence Termination Rights

The Court of Appeal has delivered a notable judgment on the interpretation of term and termination provisions in intellectual property licence agreements.

United Kingdom IP

GW

Gowling WLG

Stacked: The New Shape Of The Supplement Industry

United Kingdom Healthcare

A

AlixPartners

EU General Court: Technical Vaccine Data Does Not Have To Be Disclosed On Request

United Kingdom Healthcare

A

Altius

Pharma: Key UK Legal Developments From 2025

Worldwide Healthcare

KL

Herbert Smith Freehills Kramer LLP

Listing And Prospectus Regime – FCA Consultation On Miscellaneous Amendments

United Kingdom Commercial

KL

Herbert Smith Freehills Kramer LLP

Snapshot: Key European Pharma Regulatory, IP And Competition Developments From 2025 For The Pharmaceutical Sector

European Union Healthcare

KL

Herbert Smith Freehills Kramer LLP

Provisional Text Of The Political Agreement On The Reform To The EU Regulatory Framework For Medicinal Products Is Published

United Kingdom Healthcare

AP

Arnold & Porter

'WHOOP WHOOP' - A Wearable Focused On Women's Health

United Kingdom Healthcare

MC

Marks & Clerk

Virtual And Digital Health Digest – February 2026

United Kingdom Healthcare

AP

Arnold & Porter

Changes To UK Clinical Trials Regulations Take Effect April 28, 2026. New Versions Of UK Model Clinical Trial Agreement Forms Pending

United Kingdom Healthcare

CM

Crowell & Moring LLP

New Injectable Bandages To Reduce Bleed Time By Almost 70%

United Kingdom IP

MC

Marks & Clerk

Age Assurance In 2026: What Do Digital Businesses Operating In The UK And EU Need To Know?

United Kingdom Privacy

LS

Lewis Silkin

Travers Smith's Sustainability Insights: Reporting Requirements Still Shifting

United Kingdom Commercial

TS

Travers Smith LLP

FinTech Global FS Regulatory Round-up - W/e 24 April 2026

Worldwide Technology

KL

Herbert Smith Freehills Kramer LLP

Charting The EU AI Act Timeline – Key Dates From Adoption To Application

European Union Technology

LS

Lewis Silkin

UK Employment Rights Act 2025 – April 2026 Changes: What Employers Need To Know (Video)

United Kingdom Employment

AG

Akin Gump Strauss Hauer & Feld LLP

Five Governance Essentials To Reduce False Claims Act Risk

Federal False Claims Act (FCA) enforcement continues to be a top risk for healthcare and life sciences organizations, with settlements reaching a record high in 2025

United Kingdom Commercial

A

AlixPartners

An IP Guide To Biosimilars

A biosimilar is defined by the European Medicines Agency (EMA) as: "a biological medicine highly similar to another biological medicine already approved in the EU...

United Kingdom IP

B

Boult Wade Tennant

UK Government Sets Out 2026 Branded Medicines Statutory Scheme Repayment Rate

The UK Department of Health and Social Care (DHSC) has proposed to set the repayment percentage on sales of branded "newer" prescription-only medicines to the NHS at 16.5% for 2026...

United Kingdom Healthcare

AP

Arnold & Porter

Healthcare & Life Sciences – AI Readiness & Integration Questionnaire

Artificial Intelligence (AI) is rapidly changing the way people work across the life sciences and healthcare sector.

United Kingdom Healthcare

AG

Addleshaw Goddard

UK PMCPA Releases New Guidance On Package Deals: Key Takeaways For Industry

United Kingdom Healthcare

AP

Arnold & Porter

UK's Data (Use And Access) Act: What Life Sciences Companies Need To Know

United Kingdom Healthcare

AP

Arnold & Porter

Is Change On The Horizon For The UK Product Liability Regime? [Updated]

United Kingdom Healthcare

AP

Arnold & Porter

European Real Estate: A Market Ready To Mobilize

European Union Real Estate

SR

McDermott Will & Schulte

Trends In Therapeutic Innovation

United Kingdom Healthcare

B

Boult Wade Tennant

UK Clinical Trials Reform: Early Growth Indicators And Key MHRA Guidance

United Kingdom Healthcare

AP

Arnold & Porter

Agritech Thymes: Unlocking The Soil Microbiome: Driving Agritech Innovation In The UK

United Kingdom IP

HL

HGF Ltd

The Antibody Series #1 Quality Characteristics (CQAs) In Antibody Claims: When The Test Method Can Remain Outside The Claim

United Kingdom IP

HL

HGF Ltd

UK Government To Issue Guidance On Industry Payment Transparency

United Kingdom Healthcare

AP

Arnold & Porter

Celltrion And Sandoz Launch Their Aflibercept Biosimilars In Europe

European Union Healthcare

GP

Goodwin Procter LLP

Agritech Thymes: Unlocking The Soil Microbiome: Driving Agritech Innovation In The UK

Although much of my professional experience has focused on the human microbiome, I have always had an interest in the soil and plant microbiome.

United Kingdom IP

HL

HGF Ltd

The Antibody Series #1 Quality Characteristics (CQAs) In Antibody Claims: When The Test Method Can Remain Outside The Claim

Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs)...

United Kingdom IP

HL

HGF Ltd

UK Government To Issue Guidance On Industry Payment Transparency

Following a public consultation, the UK government has outlined plans to publish guidance on disclosing payments made by the medicines and medical devices industries to the healthcare sector.

United Kingdom Healthcare

AP

Arnold & Porter

Celltrion And Sandoz Launch Their Aflibercept Biosimilars In Europe

On November 27, 2025, Celltrion announced that Health Canada approved EYDENZELT® (aflibercept-boav), a biosimilar referencing Regeneron's EYLEA® (aflibercept)...

European Union Healthcare

GP

Goodwin Procter LLP

What Will 2026 Hold For Life Sciences And Biopharma?

United Kingdom Commercial

AO

A&O Shearman

SPC Waiver: No MA? UK Says Ok

The UK Patents Court has confirmed that manufacturers using the SPC manufacturing waiver can notify without overseas marketing authorisation (MA) numbers, provided updates follow when available.

United Kingdom IP

PC

Potter Clarkson

Current Life Sciences Insurance Trends And The Imperative For Specialised Coverage

The life sciences industry, valued at $412.74 billion in 2023 and projected to reach $727.1 billion by 2025, faces unprecedented complexity.

United Kingdom Healthcare

BJ

Browne Jacobson

Confidentiality In Clinical Trials: Arbitration As The Preferred Route For Dispute Resolution

In the life sciences sector, clinical trials are the engine of innovation but also a source of risk.

United Kingdom Litigation

BJ

Browne Jacobson

Climate Resilient Crops – Mitigating The Risks Of Climate Change

Global temperatures are reaching unprecedented levels and action is needed to combat the effects of climate change.

United Kingdom Environment

JA

J A Kemp LLP

Cross-border Collaboration In Life Sciences: How To Make It Work

Worldwide Healthcare

BJ

Browne Jacobson

Unlocking Value Creation In Healthcare: How AI Can Reverse Private Equity's Return Challenges - Part 1: HealthTech And Tech-enabled Services

United Kingdom Healthcare

A

AlixPartners

Hot Topics: Life Sciences - October 2025

United Kingdom Healthcare

AG

Addleshaw Goddard

How MHRA's International Reliance Is Shaping UK Medicine Regulation

United Kingdom Healthcare

BJ

Browne Jacobson

Technology-Enabled Care In The UK: Legal And Technical Developments To Watch

United Kingdom Healthcare

BJ

Browne Jacobson

The Dog That Barks: The UK's CMA Is Proposing Major Reforms To Veterinary Businesses

United Kingdom Healthcare

AP

Arnold & Porter

Arbitrating Innovation: Resolving IP Disputes In The Life Sciences Sector

United Kingdom Healthcare

BJ

Browne Jacobson

The Importance Of AI In The Development Life Sciences

United Kingdom Healthcare

BJ

Browne Jacobson

MHRA And NICE Launch Aligned Approvals Pathway

United Kingdom Healthcare

AP

Arnold & Porter

Biopharma M&A Activity – Strategics Continue To Lead The Way

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Venture Investment In Life Sciences – Activity Update & Outlook (US & Europe)

Worldwide Healthcare

KL

Herbert Smith Freehills Kramer LLP

EU Data Act: Is Your Business Ready?

European Union Privacy

AG

Addleshaw Goddard

AI In Medical Devices: Patent Eligibility

United Kingdom IP

MC

Marks & Clerk

Article 22 Trends In Pharma M&A: Call-In Powers And Timing

United Kingdom Healthcare

AP

Arnold & Porter

Interview With Citrine Informatics: AI, Data, And The Future Of Materials Science

United Kingdom Technology

KL

Keltie LLP

See more

Latest Videos

See more

Legally Vocal: Patrick Duxbury On His COVID-19 Vaccine Work And 20-Year Career In Life Sciences (Video)

GW

Gowling WLG

Webinar: Supplementary Protection Certificates - Part Two (Video)

D

Dehns

EU And UK Compliance Considerations In Remote Promotion Training And Medical Information Services (Video)

AP

Arnold & Porter

Claim One – #01 EPO Oral Proceedings (Video)

H

HLK

Deloitte Global TMT Predictions 2018 Machine Learning (Video)

D

Deloitte

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More